Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001780851-25-000002

Chief Scientific Officer sold 10,000 shares at $14.82 ($148,200)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROBINS HARLAN S · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-11-10 Sale : show line 1 in the form 10b5-1 −10,000 $14.82 $148,200 1,269,524 D
Open-market sales · 10,000 sh · avg $14.82 · $148,200
Loading xslF345X05/primary_doc.xml…